Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
797.00    -13.00 (-1.60%)
Bid:
796.00
Ask:
798.00
Spread: 2.00 (0.251%)
Market Cap: £905.93m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Board Change

Today 09:42

RNS Number : 3765K
Fevertree Drinks PLC
30 June 2026
 

30 June 2026

 

Fevertree Drinks plc

 ("Fever-Tree" or the "Company")

 

Board Change

 

 

Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that Laura Hagan has informed the Board of her decision to step down as a Non-Executive Director of the Company with effect from the end of July 2026.

 

Laura joined the Board in May 2021 and has served as Chair of the Remuneration Committee and as a member of the Audit and Nomination Committees. During her tenure, she has made a significant contribution to the Board, bringing extensive HR, governance, listed company and relevant industry experience, together with valuable insight and constructive challenge as the business has continued to evolve.

 

Commenting on Laura's departure, Domenic De Lorenzo, Chair of Fever-Tree, said: "On behalf of the Board, I would like to thank Laura for her commitment and valued contribution over the past five years. She has been an excellent colleague, providing thoughtful counsel and sound judgement throughout her time with Fever-Tree. We are grateful for her support and wish her every success for the future and the rest of her portfolio career."

 

Laura Hagan said: "It has been a privilege to serve on the Fever-Tree Board and to work alongside Dom, Tim, Andy and my fellow Directors during an exciting period for the business. Fever-Tree is a fantastic company with a strong brand, talented people and significant opportunities ahead. I wish the Board and everyone at Fever-Tree continued success for the future."

 

Following Laura's departure, David Lapp will assume the role of Chair of the Remuneration Committee. David joined the Board in January 2024 and brings extensive international commercial and leadership experience.

 

 

 Ends

 

For further information:

 

Investor queries

Steve Nightingale, Investor Relations Director I steve.nightingale@fever-tree.com I

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

 

Nominated Advisor and Broker - Investec Bank plc

David Flin I +44 (0)20 7597 5970

Corporate Broker - Jefferies International Limited

Ed Matthews I Richard Taylor I +44 (0)20 7029 8000

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171; Anjali Unnikrishnan +44 (0) 7826 534 233

Notes to Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 90 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASDSSASEMSELM
Date   Source Headline
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20252:11 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSCommencement of share buyback programme
10th Feb 20251:35 pmRNSHolding(s) in Company
7th Feb 20254:35 pmRNSHolding(s) in Company
7th Feb 20254:07 pmRNSHolding(s) in Company
7th Feb 20254:05 pmRNSHolding(s) in Company - correction
6th Feb 202511:39 amRNSHolding(s) in Company
5th Feb 20255:39 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSCompletion of Share Issuance to Molson Coors
3rd Feb 202512:20 pmRNSStandard form for notification of major holdings
30th Jan 20253:01 pmRNSDirector/PDMR Shareholding
30th Jan 20257:02 amRNSUS Strategic Partnership with Molson Coors
20th Jan 20257:00 amRNSAppointment Of Corporate Broker
6th Jan 20252:15 pmRNSStandard form for notification of major holdings
2nd Dec 202411:47 amRNSStandard form for notification of major holdings
2nd Dec 20247:00 amRNSBlock Listing Return
2nd Dec 20247:00 amRNSTotal Voting Rights
28th Nov 20245:12 pmRNSStandard form for notification of major holdings
18th Sep 20242:42 pmRNSStandard form for notification of major holdings
12th Sep 20247:00 amRNSFY24 Interim Results to 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTotal Voting Rights
6th Jun 20241:29 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Trading Statement
3rd Jun 20247:00 amRNSBlock Listing Return
3rd Jun 20247:00 amRNSTotal Voting Rights
9th May 20247:00 amRNSNotice of AGM
7th May 20247:00 amRNSGrant of Options
1st May 20247:00 amRNSTotal Voting Rights
27th Mar 20247:00 amRNSHolding(s) in Company
26th Mar 20247:00 amRNSFY23 Preliminary Results to 31 December 2023
25th Jan 202412:05 pmRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSFY23 pre-close trading update
18th Jan 20242:30 pmRNSBlock Admission Application
18th Jan 20242:30 pmRNSAdmission Application
14th Dec 20232:33 pmRNSDirectorate Change
1st Dec 20237:00 amRNSBlock Listing Return
1st Dec 20237:00 amRNSTotal Voting Rights
1st Nov 20238:55 amRNSTotal Voting Rights
26th Oct 20233:25 pmRNSDirector/PDMR Shareholding
28th Sep 20236:20 pmRNSHolding(s) in Company
14th Sep 202312:18 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.